the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children
Launched by CHILDREN'S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jun 16, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how high-calorie oral nutritional supplements can help malnourished children aged 1 to 3 years. The goal is to see if these supplements can improve their growth, weight, and overall development, including their gut health and immune function. Children in the study will receive daily nutritional education and either the high-calorie supplements or just dietary guidance without the supplements. This research could help create better care strategies for malnourished children in China.
To participate, children must be between 1 and 3 years old and show signs of malnutrition, such as being underweight or having a low body mass index (BMI). Their guardians must also agree to join the study. Unfortunately, children with certain health conditions, like severe diseases or specific genetic disorders affecting growth, cannot take part. If eligible, participants will receive support and monitoring throughout the trial to ensure their safety and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 1-3 years
- • BMI for Age Z-score\<-2
- • Height-for-age z score\<-2
- • Total daily energy intake\<75% of recommended nutrient intake
- • The child's guardian is willing to participate in this study and sign an informed consent form.
- Exclusion Criteria:
- • Chronic or severe infectious disease (e.g., chronic hepatitis, HIV or tuberculosis infection)
- • Certain congenital or genetic diseases affecting physical growth and development (congenital heart disease, Down's syndrome, infantile anorexia nervosa, etc.), malignancies and use of drugs (diuretics, appetite stimulants, steroids and growth hormones, etc.)
- • Severe gastrointestinal disorders (e.g., celiac disease, short bowel syndrome, inflammatory bowel disease, etc.)
- • Acute and chronic respiratory/digestive tract infections within 2 weeks prior to enrollment
- • Allergy or contraindication to any of the ingredients in the high-energy total nutrition formula used in this study
- • Have used high-energy enteral nutrition preparations for the last 3 months
About Children's Hospital Of Chongqing Medical University
The Children's Hospital of Chongqing Medical University is a leading pediatric healthcare institution in China, dedicated to advancing child health through innovative clinical research and comprehensive medical care. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating new treatments and interventions for a wide range of pediatric conditions. With a commitment to improving health outcomes for children, the institution leverages its expertise in pediatric medicine, state-of-the-art facilities, and collaboration with academic and research partners to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Nanchang, Jiangxi, China
Changsha, Hunan, China
Chongqing, Chongqing, China
Hefei, Anhui, China
Beijing, Beijing, China
Guangzhou, Guangdong, China
Guiyang, Guizhou, China
Baoji, Shanxi, China
Xianyang, Shanxi, China
Chengdu, Sichuan, China
Kunming, Yunnan, China
Patients applied
Trial Officials
Li Chen, doctor
Study Director
Children's Hospital of Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported